Lukas Hunziker
Association between caseload volume and outcomes in left ventricular assist device implantations - a EUROMACS analysis.
Mihalj M, Reineke D, Just I, Mulzer J, Cholevas N, Hoermandinger C, Veen K, Luedi M, Heinisch P, Potapov E, Gummert J, Mohacsi P, Hagl C, Faerber G, Zimpfer D, de By T, Meyns B, Gustafsson F, Hunziker L, Siepe M, Schober P, Schoenrath F. Association between caseload volume and outcomes in left ventricular assist device implantations - a EUROMACS analysis. Eur J Heart Fail 2024
29.08.2024Association between caseload volume and outcomes in left ventricular assist device implantations - a EUROMACS analysis.
29.08.2024Eur J Heart Fail 2024
Mihalj Maks, Reineke David, Just Isabell A, Mulzer Johanna, Cholevas Nikolaos, Hoermandinger Christoph, Veen Kevin, Luedi Markus M, Heinisch Paul Philipp, Potapov Evgenij, Gummert Jan F, Mohacsi Paul, Hagl Christian, Faerber Gloria, Zimpfer Daniel, de By Theo M M H, Meyns Bart, Gustafsson Finn, Hunziker Lukas, Siepe Matthias, Schober Patrick, Schoenrath Felix
Twenty-Year Trends in the Incidence and Outcome of Cardiogenic Shock in AMIS Plus Registry
Hunziker L, Pilgrim T, Rickli H, Erne P, Urban P, Cuculi F, Pedrazzini G, Jeger R, Radovanovic D, AMIS Plus Registry Investigators are listed in alphabetic order with the names of the local principal investigators. Twenty-Year Trends in the Incidence and Outcome of Cardiogenic Shock in AMIS Plus Registry. Circ Cardiovasc Interv 2019; 12:e007293.
01.01.2019Twenty-Year Trends in the Incidence and Outcome of Cardiogenic Shock in AMIS Plus Registry
01.01.2019Circ Cardiovasc Interv 2019; 12:e007293
Hunziker Lukas, Pilgrim Thomas, Rickli Hans, Erne Paul, Urban Philip, Cuculi Florim, Pedrazzini Giovanni, Jeger Raban, Radovanovic Dragana, AMIS Plus Registry Investigators are listed in alphabetic order with the names of the local principal investigators
Ultrathin-strut, biodegradable-polymer, sirolimus-eluting stents versus thin-strut, durable-polymer, everolimus-eluting stents for percutaneous coronary revascularisation: 5-year outcomes of the BIOSCIENCE randomised trial
Pilgrim T, Jüni P, Eberli F, Hunziker L, Cuculi F, Kaiser C, Weilenmann D, Cook S, Siontis G, Moarof I, Muller O, Tüller D, Roffi M, Heg D, Piccolo R, Windecker S. Ultrathin-strut, biodegradable-polymer, sirolimus-eluting stents versus thin-strut, durable-polymer, everolimus-eluting stents for percutaneous coronary revascularisation: 5-year outcomes of the BIOSCIENCE randomised trial. Lancet 2018; 392:737-746.
28.08.2018Ultrathin-strut, biodegradable-polymer, sirolimus-eluting stents versus thin-strut, durable-polymer, everolimus-eluting stents for percutaneous coronary revascularisation: 5-year outcomes of the BIOSCIENCE randomised trial
28.08.2018Lancet 2018; 392:737-746
Pilgrim Thomas, Jüni Peter, Eberli Franz R, Hunziker Lukas, Cuculi Florim, Kaiser Christoph, Weilenmann Daniel, Cook Stéphane, Siontis George C M, Moarof Igal, Muller Olivier, Tüller David, Roffi Marco, Heg Dik, Piccolo Raffaele, Windecker Stephan